Blaine Pharmaceuticals : Makers of MAG-OX 400

	Ronald J. Elin, MD, PhD Consulting Medical Director to Blaine Pharmaceuticals and Chair of the Medical Advisory Board. Professor of Pathology, Chairman of the Department of Pathology and Laboratory Medicine, and Director of Laboratories at the University of Louisville Hospital, Louisville, Kentucky.	Robert M. McLean, MD Assistant Clinical Professor of Medicine at Yale University School of Medicine and a member of New Haven Medical Group, PC, New Haven, Connecticut.
J. Wesley Alexander, MD, ScD Professor of Surgery at the University of Cincinnati College of Medicine and Director of the Surgical Immunology Laboratory Department of Surgery at the University of Cincinnati Medical Center, Cincinnati, Ohio.	Lawrence M. Resnick, MD Professor of Medicine at the Hypertension Center of the Cornell University Medical Center, New York, New York. Dr. Resnick is also Executive Editor of the American Journal of Hypertension and a Fellow of the American College of Nutrition.
Ezra A. Amsterdam, MD Professor of Internal Medicine and Director of the Cardiac Care Unit, Division of Cardiovascular Medicine, Department of Internal Medicine at the University of California School of Medicine, Davis, California.	Robert K. Rude, MD Professor of Medicine, University of Southern California School of Medicine, Los Angeles, California.
John A. Jernigan, MD Clinical Assistant Professor of Medicine of the Internal Medicine Residency Program at the University of Alabama School of Medicine. He is the Founder and Principal Investigator of Mulberry Clinical Research, Montgomery, Alabama.	Michael Shechter, MD, MA, FACC, FESC Senior Cardiologist at Sheba Medical Center, lecturer at the Sackler School of Medicine, Tel Aviv University, and Chief Cardiologist of MDA, Israel. For the past three years he was a Save A Heart Foundation Research Scientist at the Preventive & Rehabilitative Cardiac Center, Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, California.